These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18461633)

  • 41. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
    Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
    Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous subcutaneous insulin infusion (CSII) reduces counter-regulatory hormone concentrations in a patient receiving enteral hyperalimentation.
    Bergman M; Ravikumar S; Auerhahn C; Del Savio N; Savino J; Hendler R; Jacob R; Felig P
    Diabetes Res; 1986 Nov; 3(9):487-8. PubMed ID: 3103971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes.
    Syed A; Hussain S; Nightingale P; De P; Charlton MH; Gangopadhyay K; Barnett AH; Narendran P
    Curr Med Res Opin; 2007 Dec; 23(12):2921-7. PubMed ID: 17931464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes.
    Djurhuus MS; Klitgaard NA; Pedersen KK; Blaabjerg O; Altura BM; Altura BT; Henriksen JE
    Metabolism; 2001 Dec; 50(12):1409-17. PubMed ID: 11735085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes.
    Lin CH; Hsieh SH; Sun JH; Tsai JS; Huang YY
    Sci Rep; 2015 Nov; 5():16968. PubMed ID: 26607841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.
    Van Ballegooie E; Reitsma WD; Sluiter WJ; Doorenbos H
    Neth J Med; 1984; 27(5):185-92. PubMed ID: 6427640
    [No Abstract]   [Full Text] [Related]  

  • 47. No apparent local effect of insulin on microdialysis continuous glucose- monitoring measurements.
    Hermanides J; Wentholt IM; Hart AA; Hoekstra JB; DeVries JH
    Diabetes Care; 2008 Jun; 31(6):1120-2. PubMed ID: 18332157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence.
    Fhärm E; Rolandsson O; Weinehall L
    Scand J Public Health; 2008 Jan; 36(1):69-75. PubMed ID: 18426787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study.
    Sobenin IA; Nedosugova LV; Filatova LV; Balabolkin MI; Gorchakova TV; Orekhov AN
    Acta Diabetol; 2008 Mar; 45(1):1-6. PubMed ID: 17823766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
    Li Y; Xu W; Liao Z; Yao B; Chen X; Huang Z; Hu G; Weng J
    Diabetes Care; 2004 Nov; 27(11):2597-602. PubMed ID: 15504992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early onset insulin-dependent diabetes mellitus as an initial manifestation of aceruloplasminaemia.
    Muroi R; Yagyu H; Kobayashi H; Nagata M; Sato N; Ideno J; Fujita N; Ando A; Okada K; Takiyama Y; Nagasaka S; Miyajima H; Nakano I; Ishibashi S
    Diabet Med; 2006 Oct; 23(10):1136-9. PubMed ID: 16978380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes.
    Park S; Choi SB
    Am J Clin Nutr; 2002 Apr; 75(4):728-33. PubMed ID: 11916760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a structured educational programme for type 2 diabetes patients seen in private practice.
    Boegner C; Fontbonne A; Gras Vidal MF; Mouls P; Monnier L;
    Diabetes Metab; 2008 Jun; 34(3):243-9. PubMed ID: 18396086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of Continuous Subcutaneous Insulin Infusion (CSII): parental and professional perceptions of self-care mastery and autonomy in children and adolescents.
    Weissberg-Benchell J; Goodman SS; Antisdel Lomaglio J; Zebracki K
    J Pediatr Psychol; 2007; 32(10):1196-202. PubMed ID: 17599966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients.
    Pouwels MJ; Tack CJ; Hermus AR; Lutterman JA
    Diabet Med; 2003 Jan; 20(1):76-9. PubMed ID: 12519325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reassessment of cardiovascular risk in diabetes.
    Jaffe JR; Nag SS; Landsman PB; Alexander CM
    Curr Opin Lipidol; 2006 Dec; 17(6):644-52. PubMed ID: 17095909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric.
    Palerm CC; Zisser H; Bevier WC; Jovanovic L; Doyle FJ
    Diabetes Care; 2007 May; 30(5):1131-6. PubMed ID: 17303792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effect of intensive insulin therapy on specific long-term complications in type II diabetes].
    Podrouzková B
    Vnitr Lek; 1994 May; 40(5):306-9. PubMed ID: 8023472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.
    Lawson P; Home PD; Bergenstal R
    Diabetes; 1985 Aug; 34 Suppl 3():27-30. PubMed ID: 3894126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.
    Debacker N; Nobels F; Vandenberghe H; Van Crombrugge P; Scheen A; Van Casteren V
    Diabet Med; 2008 Feb; 25(2):179-85. PubMed ID: 18290859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.